Cargando…
Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges
RNA interference (RNAi) is an evolutionarily conserved, endogenous process for post-transcriptional regulation of gene expression. Although RNAi therapeutics have recently progressed through the pipeline toward clinical trials, the application of these as ideal, clinical therapeutics requires the de...
Autores principales: | Zhou, Jiehua, Shum, Ka-To, Burnett, John C., Rossi, John J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649006/ https://www.ncbi.nlm.nih.gov/pubmed/23667320 http://dx.doi.org/10.3390/ph6010085 |
Ejemplares similares
-
Aptamer-Based Therapeutics: New Approaches to Combat Human Viral Diseases
por: Shum, Ka-To, et al.
Publicado: (2013) -
Current Progress of RNA Aptamer-Based Therapeutics
por: Zhou, Jiehua, et al.
Publicado: (2012) -
Nucleic Acid Aptamers as Potential Therapeutic and Diagnostic Agents for Lymphoma
por: Shum, Ka-To, et al.
Publicado: (2013) -
RNAi-based therapeutics–current status, challenges and prospects
por: Tiemann, Katrin, et al.
Publicado: (2009) -
Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics
por: Gentile, Emanuela, et al.
Publicado: (2017)